DK1165576T3 - Fremgangsmåde til fremstilling af amin-platin-komplekser - Google Patents

Fremgangsmåde til fremstilling af amin-platin-komplekser

Info

Publication number: DK1165576T3
Authority: DK; Denmark
Prior art keywords: amine; preparation; platinum complexes; complexes; platinum
Prior art date: 1999-04-13

Application number

DK00918620T

Other languages

English (en)

Inventor

Ernest S Y Wong

Christen M Giandomenico

Original Assignee

Anormed Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-13

Filing date

2000-04-11

Publication date

2006-03-27

2000-04-11 Application filed by Anormed Inc filed Critical Anormed Inc

2006-03-27 Application granted granted Critical

2006-03-27 Publication of DK1165576T3 publication Critical patent/DK1165576T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

DK00918620T 1999-04-13 2000-04-11 Fremgangsmåde til fremstilling af amin-platin-komplekser DK1165576T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12893999P	1999-04-13	1999-04-13

Publications (1)

Publication Number	Publication Date
DK1165576T3 true DK1165576T3 (da)	2006-03-27

Family

ID=22437722

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00918620T DK1165576T3 (da)	1999-04-13	2000-04-11	Fremgangsmåde til fremstilling af amin-platin-komplekser

Country Status (32)

Country	Link
US (1)	US6518428B1 (da)
EP (1)	EP1165576B1 (da)
JP (1)	JP4756669B2 (da)
KR (1)	KR100711955B1 (da)
CN (3)	CN1916009B (da)
AR (1)	AR043084A1 (da)
AT (1)	ATE309257T1 (da)
AU (1)	AU770006B2 (da)
BG (1)	BG65429B1 (da)
BR (1)	BR0009780B1 (da)
CA (1)	CA2368849C (da)
CY (1)	CY1104965T1 (da)
CZ (1)	CZ303156B6 (da)
DE (1)	DE60023859T2 (da)
DK (1)	DK1165576T3 (da)
EE (1)	EE04747B1 (da)
ES (1)	ES2253214T3 (da)
HK (2)	HK1039336B (da)
HU (1)	HUP0200748A3 (da)
IL (1)	IL145671A0 (da)
IS (1)	IS2711B3 (da)
MX (1)	MXPA01010430A (da)
MY (1)	MY122706A (da)
NO (1)	NO330429B1 (da)
NZ (1)	NZ514736A (da)
PL (1)	PL202731B1 (da)
RU (1)	RU2245340C2 (da)
SK (1)	SK286374B6 (da)
TW (1)	TWI289565B (da)
UA (1)	UA71614C2 (da)
WO (1)	WO2000061590A1 (da)
ZA (1)	ZA200107965B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9502799D0 (en) *	1995-02-14	1995-04-05	Johnson Matthey Plc	Improvements in platinum complexes
US6413953B1 (en) *	1999-04-13	2002-07-02	Anormed Inc.	Pt(IV) antitumor agent
BR0009780B1 (pt)	1999-04-13	2013-09-24		processo para preparar um complexo de cisplatina
GB0011903D0 (en) *	2000-05-18	2000-07-05	Astrazeneca Ab	Combination chemotherapy
US6806289B1 (en) *	2000-07-14	2004-10-19	Stephen J. Lippard	Coordination complexes, and methods for preparing by combinatorial methods, assaying and using the same
US6894049B1 (en) *	2000-10-04	2005-05-17	Anormed, Inc.	Platinum complexes as antitumor agents
RS50605B (sr)	2004-02-18	2010-05-07	Gpc Biotech Ag.	Satraplatina za tretiranje rezistentnih i otpornih tumora
CZ296459B6 (cs) *	2004-09-14	2006-03-15	Pliva-Lachema A. S.	Perorální farmaceutická kompozice pro cílený transport komplexu platiny do kolorektální oblasti, zpusob její prípravy a tato kompozice pro pouzití jako lécivo
ES2257178B1 (es) *	2004-09-30	2007-08-16	Universidad Autonoma De Madrid	Compuestos de platino de formula trans-(ptc12(isopropilamina)(4-(hidroximetil)-piridina)) y trans-(ptc12(isopropilamina)(3-hidroximetil)-piridina y su aplicacion como farmaco antitumoral.
US8173686B2 (en)	2006-11-06	2012-05-08	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168661B2 (en) *	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8178564B2 (en) *	2006-11-06	2012-05-15	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US8168662B1 (en)	2006-11-06	2012-05-01	Poniard Pharmaceuticals, Inc.	Use of picoplatin to treat colorectal cancer
US20110033528A1 (en) *	2009-08-05	2011-02-10	Poniard Pharmaceuticals, Inc.	Stabilized picoplatin oral dosage form
TW200916094A (en) *	2007-06-27	2009-04-16	Poniard Pharmaceuticals Inc	Stabilized picoplatin dosage form
US20100260832A1 (en) *	2007-06-27	2010-10-14	Poniard Pharmaceuticals, Inc.	Combination therapy for ovarian cancer
EP2178893A4 (en) *	2007-07-16	2012-09-19	Poniard Pharmaceuticals Inc	ORAL FORMULATIONS FOR PICOPLATIN
JP2011511071A (ja) *	2008-02-08	2011-04-07	ポニアードファーマシューティカルズ，インコーポレイテッド	肺癌を治療するためのピコプラチンおよびアムルビシン
CA2763170A1 (en) *	2009-06-12	2010-12-16	Poniard Pharmaceuticals, Inc.	Improved synthesis of picoplatin
RU2451010C1 (ru) *	2011-01-11	2012-05-20	Закрытое Акционерное Общество "Ива Фарм"	Палладиево-медные катализаторы гомогенного селективного окисления тиольных групп, комбинация и композиция на их основе и способ терапевтического воздействия
CN105254679B (zh) *	2013-11-19	2018-05-15	辽宁大学	单6-(氮杂环取代)蒽醌二氯化铂配合物及其制备方法和应用
CN103860539B (zh) *	2014-04-14	2016-02-10	于迎涛	一种具有混合轴向配体的Pt（IV）类抗癌药物及制备方法
CN104231000A (zh) *	2014-08-20	2014-12-24	山东铂源药业有限公司	一种抗肿瘤药物甲啶铂的合成方法
US10987353B2 (en)	2016-05-04	2021-04-27	The Wistar Institute Of Anatomy And Biology	Methods of treating cancers overexpressing CARM1 with EZH2 inhibitors and platinum-based antineoplastic drugs
KR102137669B1 (ko) *	2019-08-05	2020-07-27	한국과학기술연구원	메탄올 또는 그 전구체 합성용 촉매, 이의 제조방법 및 이를 이용한 메탄올 또는 그 전구체의 제조방법
AU2021306808A1 (en)	2020-07-08	2023-02-02	Dayton Therapeutics Ag	Satraplatin for use in the treatment of lymphoid neoplasms
CN113402565B (zh) *	2021-06-16	2023-07-28	中国人民解放军空军军医大学	一类含有泊沙康唑的四价铂配合物、制备方法及其应用
WO2023131524A1 (en)	2022-01-07	2023-07-13	Dayton Therapeutics Ag	Treating haematological malignancies by means of satraplatin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA805101B (en) *	1979-08-23	1981-08-26	Johnson Matthey Co Ltd	Compositions containing platinium
US4533502A (en)	1983-02-22	1985-08-06	Rochon Fernande D	Platinum (II) compounds and their preparation
EP0167310B1 (en) *	1984-06-27	1991-05-29	Johnson Matthey Public Limited Company	Platinum co-ordination compounds
US5244919A (en)	1988-02-02	1993-09-14	Johnson Matthey, Inc.	Pt(IV) complexes as anti-tumor agents
GB9105037D0 (en)	1991-03-09	1991-04-24	Johnson Matthey Plc	Improvements in chemical compounds
GB9502799D0 (en) *	1995-02-14	1995-04-05	Johnson Matthey Plc	Improvements in platinum complexes
US5547982A (en) *	1995-02-27	1996-08-20	Johnson Matthey, Inc.	Anti-tumor platinum complexes
CA2367282A1 (en)	1999-03-19	2000-09-28	Simon Fricker	Pharmaceutical compositions comprising metal complexes
BR0009780B1 (pt)	1999-04-13	2013-09-24		processo para preparar um complexo de cisplatina

2000
- 2000-04-11 BR BRPI0009780-2B1A patent/BR0009780B1/pt not_active IP Right Cessation
- 2000-04-11 MX MXPA01010430A patent/MXPA01010430A/es active IP Right Grant
- 2000-04-11 WO PCT/CA2000/000385 patent/WO2000061590A1/en active IP Right Grant
- 2000-04-11 ES ES00918620T patent/ES2253214T3/es not_active Expired - Lifetime
- 2000-04-11 CZ CZ20013648A patent/CZ303156B6/cs not_active IP Right Cessation
- 2000-04-11 CN CN2006101003981A patent/CN1916009B/zh not_active Expired - Lifetime
- 2000-04-11 RU RU2001130457/04A patent/RU2245340C2/ru not_active IP Right Cessation
- 2000-04-11 CN CNB008076359A patent/CN1250559C/zh not_active Expired - Fee Related
- 2000-04-11 EE EEP200100536A patent/EE04747B1/xx not_active IP Right Cessation
- 2000-04-11 CN CNB2006100093181A patent/CN100460412C/zh not_active Expired - Lifetime
- 2000-04-11 DK DK00918620T patent/DK1165576T3/da active
- 2000-04-11 DE DE60023859T patent/DE60023859T2/de not_active Expired - Lifetime
- 2000-04-11 AU AU39510/00A patent/AU770006B2/en not_active Expired
- 2000-04-11 NZ NZ514736A patent/NZ514736A/xx not_active IP Right Cessation
- 2000-04-11 HU HU0200748A patent/HUP0200748A3/hu unknown
- 2000-04-11 CA CA2368849A patent/CA2368849C/en not_active Expired - Fee Related
- 2000-04-11 PL PL351612A patent/PL202731B1/pl not_active IP Right Cessation
- 2000-04-11 AT AT00918620T patent/ATE309257T1/de active
- 2000-04-11 US US09/547,074 patent/US6518428B1/en not_active Expired - Lifetime
- 2000-04-11 KR KR1020017013049A patent/KR100711955B1/ko not_active IP Right Cessation
- 2000-04-11 SK SK1468-2001A patent/SK286374B6/sk not_active IP Right Cessation
- 2000-04-11 IL IL14567100A patent/IL145671A0/xx not_active IP Right Cessation
- 2000-04-11 EP EP00918620A patent/EP1165576B1/en not_active Expired - Lifetime
- 2000-04-11 JP JP2000610861A patent/JP4756669B2/ja not_active Expired - Fee Related
- 2000-04-12 AR ARP000101696A patent/AR043084A1/es active IP Right Grant
- 2000-04-12 MY MYPI20001537A patent/MY122706A/en unknown
- 2000-06-23 TW TW089112556A patent/TWI289565B/zh not_active IP Right Cessation
- 2000-11-04 UA UA2001117756A patent/UA71614C2/uk unknown
2001
- 2001-09-27 ZA ZA200107965A patent/ZA200107965B/en unknown
- 2001-09-28 IS IS6092A patent/IS2711B3/is unknown
- 2001-10-12 NO NO20014957A patent/NO330429B1/no not_active IP Right Cessation
- 2001-11-08 BG BG106090A patent/BG65429B1/bg unknown
2002
- 2002-02-04 HK HK02100835.7A patent/HK1039336B/zh unknown
2006
- 2006-02-01 CY CY20061100130T patent/CY1104965T1/el unknown
2007
- 2007-08-01 HK HK07108382.2A patent/HK1100562A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU3951000A (en)	2000-11-14
CN100460412C (zh)	2009-02-11
CN1916009B (zh)	2010-12-15
NO20014957D0 (no)	2001-10-12
CA2368849A1 (en)	2000-10-19
UA71614C2 (en)	2004-12-15
DE60023859T2 (de)	2006-08-03
KR20020018189A (ko)	2002-03-07
CY1104965T1 (el)	2010-03-03
HK1039336B (zh)	2006-01-27
ES2253214T3 (es)	2006-06-01
WO2000061590A1 (en)	2000-10-19
EP1165576B1 (en)	2005-11-09
PL202731B1 (pl)	2009-07-31
CZ303156B6 (cs)	2012-05-09
HK1100562A1 (en)	2007-09-21
CN1847253A (zh)	2006-10-18
ZA200107965B (en)	2003-01-02
HK1039336A1 (en)	2002-04-19
IS2709B (is)	2011-01-15
AU770006B2 (en)	2004-02-12
EE04747B1 (et)	2006-12-15
MY122706A (en)	2006-04-29
JP2002541263A (ja)	2002-12-03
IS6092A (is)	2001-09-28
MXPA01010430A (es)	2002-03-27
CN1916009A (zh)	2007-02-21
HUP0200748A3 (en)	2010-01-28
HUP0200748A2 (hu)	2002-07-29
SK286374B6 (sk)	2008-08-05
AR043084A1 (es)	2005-07-20
BG65429B1 (bg)	2008-07-31
EP1165576A1 (en)	2002-01-02
BR0009780B1 (pt)	2013-09-24
JP4756669B2 (ja)	2011-08-24
ATE309257T1 (de)	2005-11-15
EE200100536A (et)	2003-02-17
US6518428B1 (en)	2003-02-11
NO330429B1 (no)	2011-04-11
CZ20013648A3 (cs)	2002-02-13
PL351612A1 (en)	2003-05-05
IL145671A0 (en)	2002-06-30
BG106090A (en)	2002-06-28
NZ514736A (en)	2004-01-30
RU2245340C2 (ru)	2005-01-27
TWI289565B (en)	2007-11-11
KR100711955B1 (ko)	2007-05-02
BR0009780A (pt)	2002-01-02
CN1350540A (zh)	2002-05-22
CA2368849C (en)	2011-01-25
IS2711B3 (is)	2011-01-15
CN1250559C (zh)	2006-04-12
NO20014957L (no)	2001-12-03
DE60023859D1 (de)	2005-12-15
SK14682001A3 (sk)	2002-01-07

Publication	Publication Date	Title
DK1165576T3 (da)	2006-03-27	Fremgangsmåde til fremstilling af amin-platin-komplekser
DK1173431T4 (da)	2010-01-04	Fremgangsmåde til fremstilling af citalopram
DK1105382T3 (da)	2002-05-27	Fremgangsmåde til fremstilling af citalopram
DK1159274T3 (da)	2003-07-21	Fremgangsmåde til fremstilling af citalopram
FI20000564A (fi)	2001-04-16	Menetelmä nanolaminaattien valmistamiseksi
DK1147083T3 (da)	2004-08-16	Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
DK1296935T3 (da)	2009-06-22	Fremgangsmåde til fremstilling af substituerede octanoylamider
IS2223B (is)	2007-03-15	Aðferð til framleiðslu á 5-sýanóþalíði
DK1008577T4 (da)	2006-06-06	Fremgangsmåde til fremstilling af methanol
IS2261B (is)	2007-06-15	Aðferð til framleiðslu á 5-sýanóþalíði
DK1187833T3 (da)	2007-10-08	Fremgangsmåde til fremstilling af thiamethoxam
DK1028960T3 (da)	2003-08-11	Fremgangsmåde til fremstilling af thiazolidinedion
DK0985733T3 (da)	2009-06-22	Fremgangsmåde til fremstilling af cyclodextrin
DK0973769T3 (da)	2004-12-13	Fremgangsmåde til fremstilling af eprosartan
DK1228056T3 (da)	2005-01-24	Fremgangsmåde til fremstilling af citalopram
DK1203000T3 (da)	2003-06-02	Fremgangsmåde til fremstilling af phosphonomethylglycin
DK0970073T3 (da)	2005-02-21	Fremgangsmåde til fremstilling af eprosartan
DK1240173T3 (da)	2003-09-15	Fremgangsmåde til fremstilling af N-phosphonomethylglycin
DK1294694T3 (da)	2004-12-27	Fremgangsmåde til fremstilling af quinolinderivater
NO20030515D0 (no)	2003-02-03	Fremgangsmåte for fremstilling av dinapsolin
DK1165483T3 (da)	2004-07-05	Fremgangsmåde til fremstilling af carbonylfluorid
DK1012152T3 (da)	2003-02-10	Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK1005476T3 (da)	2002-03-25	Fremgangsmåde til fremstilling af rutheniumkomplekser
DK1226125T3 (da)	2005-01-24	Fremgangsmåde til fremstilling af mavesårsmidler
DK0949246T3 (da)	2003-04-07	Fremgangsmåde til fremstilling af phenoxyphenylsulfonylhalogenider